Flow Cytometry

FH Friederike Hefele
AD Alexander Ditsch
NK Niels Krysiak
CC Charles C. Caldwell
PB Peter Biberthaler
MG Martijn van Griensven
SH Stefan Huber-Wagner
MH Marc Hanschen
request Request a Protocol
ask Ask a question
Favorite

Flow cytometric analysis of T-cell subpopulations was performed on a MACSQuant® device (Miltenyi Biotec GmbH, Bergisch Gladbach, Germany). Samples were prepared as follows: within 15 min after blood draw, EDTA-treated blood was added to Schwinzer red blood cell lysis solution. After 15 min of incubation at 4°C the cells were washed and buffered with PBA and plated on 96-well round bottom plates for staining. Fc-blocking agent was added to prevent unspecific antibody binding.

After incubation we used APC-labeled anti-CD4, eFluor450™-labeled anti-CD161, and FITC-labeled anti-CD196 for detection of Th17 cells. For CD4+ Treg detection we used FITC-labeled anti-CD4, eFluor450™-labeled anti-CD25, and APC-Cy7-labeled anti-CD127. Cell activation was evaluated using PE-labeled anti-IL17A. After incubation, cells were washed and resuspended in PBA buffer for immediate flow cytometric analysis. Prior to measurements, the MACSQuant® was calibrated using MACSQuant® calibration beads according to the manufacturer's instructions.

The obtained data sets were analyzed using FlowJo Software (FlowJo LLC, Ashland, OR). After single cell selection, Th17 cells were defined as CD4+, CD161+, CD196+ cells, and CD4+ Tregs were defined as CD4+, CD25+, CD127 cells. IL-17A expression on Th17 cells was assessed by calculating the relative median fluorescence intensity (MFI) of PE on Th17 cells stained with PE-conjugated anti-IL17A antibody. To calculate the relative MFI, the MFI of PE on anti-IL17A stained cells was divided by the MFI of PE measured on Th17 cells not stained with any PE-conjugated antibody. IL-17A expression on CD4+ Tregs was assessed analogously.

Do you have any questions about this protocol?

Post your question to gather feedback from the community. We will also invite the authors of this article to respond.

post Post a Question
0 Q&A